Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis

BACKGROUND: Adjuvant targeted therapy (TT) improves relapse free survival in patients with resected BRAF mutant stage III melanoma. The outcomes and optimal management of patients who relapse after adjuvant TT is unknown. METHODS: Patients from twenty-one centres with recurrent melanoma after adjuva...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhave, Prachi, Pallan, Lalit, Long, Georgina V., Menzies, Alexander M., Atkinson, Victoria, Cohen, Justine V., Sullivan, Ryan J., Chiarion-Sileni, Vanna, Nyakas, Marta, Kahler, Katharina, Hauschild, Axel, Plummer, Ruth, Trojaniello, Claudia, Ascierto, Paolo A., Zimmer, Lisa, Schadendorf, Dirk, Allayous, Clara, Lebbe, Celeste, Maurichi, Andrea, Santinami, Mario, Roy, Severine, Robert, Caroline, Lesimple, Thierry, Patel, Sapna, Versluis, Judith M., Blank, Christian U., Khattak, Adnan, Van der Westhuizen, Andre, Carlino, Matteo S., Shackleton, Mark, Haydon, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851118/
https://www.ncbi.nlm.nih.gov/pubmed/33087895
http://dx.doi.org/10.1038/s41416-020-01121-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851118/
https://www.ncbi.nlm.nih.gov/pubmed/33087895
http://dx.doi.org/10.1038/s41416-020-01121-y

Ejemplares similares